Attached files
| file | filename |
|---|---|
| EX-10.8 - EX-10.8 - Savara Inc | svra-ex108_127.htm |
| EX-10.9 - EX-10.9 - Savara Inc | svra-ex109_128.htm |
| EX-21.1 - EX-21.1 - Savara Inc | svra-ex211_157.htm |
| EX-31.2 - EX-31.2 - Savara Inc | svra-ex312_10.htm |
| EX-4.1 - EX-4.1 - Savara Inc | svra-ex41_129.htm |
| EX-31.1 - EX-31.1 - Savara Inc | svra-ex311_11.htm |
| EX-32.1 - EX-32.1 - Savara Inc | svra-ex321_9.htm |
| 10-K - 10-K - Savara Inc | svra-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-202960, 333-188870, 333-174203, 333-164177, 333-133824, 333-127857 and 333-117022) and Form S-8 (Nos. 333-126551, 333-151903,333-174940, 333-190376, 333-198046 and 333-206330) of Savara Inc. (formerly known as Mast Therapeutics, Inc.) of our report dated March 14, 2018 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Austin, Texas
March 14, 2018